Subscribe to RSS
DOI: 10.1055/a-0880-5414
Antiplasmodial Lycorane Alkaloid Principles of the Plant Family Amaryllidaceae
Publication History
received 17 January 2019
revised 12 March 2019
accepted 14 March 2019
Publication Date:
25 March 2019 (online)
![](https://www.thieme-connect.de/media/plantamedica/201908/lookinside/thumbnails/10-1055-a-0880-5414_pmd0040-1.jpg)
Abstract
The spread of malaria is thought to have followed human expansion out of Africa some 60 – 80 thousand years ago. With its prevalence in pantropical countries of the world and epicenter localized in Africa, malaria is now considered an unnecessary burden to overworked and under-resourced healthcare structures. Plants have long afforded a fertile hunting ground for the search and identification of structurally diverse antimalarial agents, such as quinine and artemisinin. This survey examines the antiparasitic properties of the family Amaryllidaceae via the antiplasmodial activities demonstrated for its lycorane alkaloid principles. Of these, 24 were natural compounds identified in 20 species from 11 genera of the Amaryllidaceae family, whilst the remaining 28 were synthetically derived entities based on the lycorane skeleton. These were screened against ten different strains of the malarial parasite Plasmodium falciparum, wherein the parent compound lycorine was shown to be the most potent with an IC50 of 0.029 µg/mL in the FCR-3 strain seen to be the best. Structure-activity relationship studies revealed that good activities were detectable across both the natural compounds as well as the synthetically accessed derivatives. Such studies also highlighted that there are several inherent structural features that define the lycorane alkaloid antiplasmodial pharmacophore, such as the nature of its ring systems and properties of its substituents. Mechanistically, a limited number of studies confirmed that lycorane alkaloids manifest their action by targeting enzymes associated with the plasmodial FAS-II biosynthetic pathways. Overall, these alkaloids have provided useful, convenient, and accessible scaffolds for antimalarial-based drug discovery.
-
References
- 1 World Health Organization. World Malaria Report 2018. Geneva: WHO Press; 2018: 1-60
- 2 Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell 2016; 167: 610-624
- 3 Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood 2011; 117: 381-392
- 4 Wink M. Medicinal plants: a source of anti-parasitic secondary metabolites. Molecules 2012; 17: 12771-12791
- 5 Andrews KT, Fisher G, Skinner-Adams TS. Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 2014; 4: 95-111
- 6 Schwikkard S, Van Heerden FR. Antimalarial activity of plant metabolites. Nat Prod Rep 2002; 19: 675-692
- 7 Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorg Med Chem 2009; 17: 3229-3256
- 8 Jin Z, Yao G. Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep 2019; DOI: 10.1039/c8np00055g.
- 9 Bastida J, Lavilla R, Viladomat F. Chemical and biological Aspects of Narcissus Alkaloids. In: Cordell GA. ed. The Alkaloids. Amsterdam: Elsevier; 2006: 87-179
- 10 Nair JJ, Wilhelm A, Bonnet SL, van Staden J. Antibacterial constituents of the family Amaryllidaceae. Bioorg Med Chem Lett 2017; 27: 4943-4951
- 11 Nair JJ, van Staden J. Antifungal constituents of the plant family Amaryllidaceae. Phytother Res 2018; 32: 976-984
- 12 Nair JJ, van Staden J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat Prod Commun 2014; 9: 1193-1210
- 13 Meerow AW, Snijman DA. Phylogeny of Amaryllidaceae tribe Amaryllideae based on NRDNA ITS sequences and morphology. Am J Bot 2001; 88: 2321-2330
- 14 Likhitwitayawuid K, Angerhofer CK, Chai H, Pezzuto JM, Cordell GA, Ruangrungsi N. Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile . J Nat Prod 1993; 56: 1331-1338
- 15 Nair JJ, Machocho AK, Campbell WE, Brun R, Viladomat F, Codina C, Bastida J. Alkaloids from Crinum macowanii . Phytochemistry 2000; 54: 945-950
- 16 Griffiths S. Antimalarial compounds from Crinum bulbispermum (M.Sc. dissertation). Potchefstroom: North West University; 2004
- 17 Machocho A, Chhabra SC, Viladomat F, Codina C, Bastida J. Alkaloids from Crinum stuhlmannii . Planta Med 1998; 64: 679-680
- 18 Machocho AK, Bastida J, Codina C, Viladomat F, Brun R, Chhabra SC. Augustamine type alkaloids from Crinum kirkii . Phytochemistry 2004; 65: 3143-3149
- 19 Presley CC, Krai P, Dalal S, Su Q, Cassera M, Goetz M, Kingston DGI. New potently bioactive alkaloids from Crinum erubescens . Bioorg Med Chem 2016; 24: 5418-5422
- 20 Viladomat F, Bastida J, Codina C, Nair JJ, Campbell WE. Alkaloids of the South African Amaryllidaceae. In: Pandalai SG. ed. Recent Research Developments in Phytochemistry. Trivandrum: Research Signpost Publishers; 1997: 131-171
- 21 Nair JJ, Bastida J, Codina C, Viladomat F, van Staden J. Alkaloids of the South African Amaryllidaceae: a review. Nat Prod Commun 2013; 8: 1335-1350
- 22 Campbell WE, Nair JJ, Gammon DW, Bastida J, Codina C, Viladomat F, Smith PJ, Albrecht CF. Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis . Planta Med 1998; 64: 91-93
- 23 Campbell WE, Nair JJ, Gammon DW, Codina C, Bastida J, Viladomat F, Smith PJ, Albrecht CF. Bioactive alkaloids from Brunsvigia radulosa . Phytochemistry 2000; 53: 587-591
- 24 Cho N, Du Y, Valenciano AL, Fernandez-Murga ML, Goetz M, Clement J, Cassera MB, Kingston DGI. Antiplasmodial alkaloids from bulbs of Amaryllis belladonna Steud. Bioorg Med Chem Lett 2018; 28: 40-42
- 25 Herrera MR, Machocho AK, Nair JJ, Campbell WE, Brun R, Viladomat F, Codina C, Bastida J. Alkaloids from Cyrtanthus elatus . Fitoterapia 2001; 72: 444-448
- 26 Kornienko A, Evidente A. Chemistry, biology and medicinal potential of narciclasine and its congeners. Chem Rev 2008; 108: 1982-2014
- 27 Labraña J, Machocho AK, Kricsfalusy V, Brun R, Codina C, Viladomat F, Bastida J. Alkaloids from Narcissus angustifolius subsp. transcarpathicus (Amaryllidaceae). Phytochemistry 2002; 60: 847-852
- 28 Şener B, Orhan I, Stayavivad J. Antimalarial activity screening of some alkaloids and the plant extracts from Amaryllidaceae. Phytother Res 2003; 17: 1220-1223
- 29 De Andrade JP, Pigni NB, Torras-Claveria L, Berkov S, Codina C, Viladomat F, Bastida J. Bioactive alkaloid extracts from Narcissus broussonetii: mass spectral studies. J Pharm Biomed Anal 2012; 70: 13-25
- 30 Kaya GI, Sarıkaya B, Onur MA, Somer NU, Viladomat F, Codina C, Bastida J, Lauinger IL, Kaiser M, Tasdemir D. Antiprotozoal alkaloids from Galanthus trojanus . Phytochem Lett 2011; 4: 301-305
- 31 Cedrón JC, Gutiérrez D, Flores N, Ravelo AG, Estévez-Braun A. Synthesis and antiplasmodial activity of lycorine derivatives. Bioorg Med Chem 2010; 18: 4694-4701
- 32 Lin LZ, Hu SF, Chai HB, Pengsuparp T, Pezzuto JM, Cordell GA, Ruangrungsi N. Lycorine alkaloids from Hymenocallis littoralis . Phytochemistry 1995; 40: 1295-1298
- 33 Herrera MR, Machocho AK, Brun R, Viladomat F, Codina C, Bastida J. Crinane and lycorane type alkaloids from Zephyranthes citrina . Planta Med 2001; 67: 191-193
- 34 Osorio EJ, Berkov S, Brun R, Codina C, Viladomat F, Cabezas F, Bastida J. In vitro antiprotozoal activity of alkaloids from Phaedranassa dubia (Amaryllidaceae). Phytochem Lett 2010; 3: 161-163
- 35 Toriizuka Y, Kinoshita E, Kogure N, Kitajima M, Ishiyama A, Otoguro K, Yamada H, Omura S, Takayama H. New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives. Bioorg Med Chem 2008; 16: 10182-10189
- 36 Hao B, Shen SF, Zhao QJ. Cytotoxic and antimalarial alkaloids from the bulbs of Lycoris radiata . Molecules 2013; 18: 2458-2468
- 37 Müller IB, Hyde JE. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol 2010; 5: 1857-1873
- 38 Saifi MA, Beg T, Harrath AH, Altayalan FSH, Al Quraishy S. Antimalarial drugs: mode of action and status of resistance. Afr J Pharm Pharmacol 2013; 7: 148-156
- 39 Vaughan AM, OʼNeill MT, Tarun AS, Camargo N, Phuong TM, Aly ASI, Cowman AF, Kappe SHI. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 2009; 11: 506-520